Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision marker changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:58.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The NCT02243605 study page now shows a 403 Forbidden error, replacing the former study details with an error page. The study record and related information on the page are no longer accessible.
    Difference
    20%
    Check dated 2026-09-20T20:44:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, reflecting a minor update to the study record metadata.
    Difference
    0.0%
    Check dated 2026-08-30T15:37:34.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record now shows updated date metadata: the latest update date (2026-08-18) and the QC-verified update date (2026-07-24), along with a revised estimated study completion date (2027-07-23). Older date entries (2026-06-12, 2026-07-11, 2026-06-11) were removed to reflect the new record state.
    Difference
    0.2%
    Check dated 2026-08-23T15:27:01.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.6.4 to v3.6.5. This represents a minor platform update rather than any change to study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-08T23:40:19.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, representing a small backend or documentation update. It does not change any study information displayed to users.
    Difference
    0.0%
    Check dated 2026-07-25T17:52:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.